{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:46:46Z","timestamp":1787611606568,"version":"build-2736575974"},"reference-count":46,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Non-alcoholic liver disease (NAFLD) may be associated with cardiovascular diseases; however, only a few studies have analyzed this relationship. We aimed to assess the epidemiologic data and the association between NAFLD and acute myocardial infarction (AMI) in the United States. Methods: The National Inpatient Sample (NIS) database 2016\u20132019 was queried using ICD10-CM diagnostic codes to identify hospitalizations of AMI + NAFLD. Essential demographic variables were analyzed to determine the disparities in the prevalence of AMI hospitalizations and deaths among NAFLD patients. Univariate and multivariate logistic regression models determined the association between NAFLD and AMI hospitalizations and death. Results: Among the total 5450 NAFLD patients hospitalized with AMI, 5.11% (279) died. Females were less likely to be admitted and die due to AMI than males. Younger patients (&lt;50) were less likely to be hospitalized and die than those \u226550. Compared to the white population, black patients were less likely; however, Hispanics, Asians, and Pacific Islanders were more likely to be hospitalized. Race was not found to affect hospital mortality. On multivariate analysis, NAFLD was associated with higher odds of AMI hospitalization [OR 1.55, 95% CI 1.51\u20131.60, p &lt; 0.01] and death [OR 1.96, 95% CI 1.74\u20132.21, p &lt; 0.01]. Conclusions: Older white males with NAFLD had a higher prevalence of AMI hospitalizations and mortality.<\/jats:p>","DOI":"10.3390\/jcm13226946","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T10:44:37Z","timestamp":1732013077000},"page":"6946","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Disparities in the Prevalence of Hospitalizations and In-Hospital Mortality Due to Acute Myocardial Infarction Among Patients with Non-Alcoholic Fatty Liver Disease: A Nationwide Retrospective Study"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3484-1994","authenticated-orcid":false,"given":"Umar","family":"Hayat","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Geisinger Wyoming Valley Medical Center, Wilkes-Barre, PA 18705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Kamal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4323-3440","authenticated-orcid":false,"given":"Muhammad U.","family":"Kamal","sequence":"additional","affiliation":[{"name":"Essen Healthcare System, Bronx, NY 10458, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasique","family":"Mirza","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Geisinger Wyoming Valley Medical Center, Wilkes-Barre, PA 18705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq A.","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Geisinger Wyoming Valley Medical Center, Wilkes-Barre, PA 18705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manesh K.","family":"Gangwani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Toledo, Toledo, OH 43614, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8544-9039","authenticated-orcid":false,"given":"Dushyant S.","family":"Dahiya","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, The University of Kansas School of Medicine, Kansas City, KS 66103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassam","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, ECU Health Medical Center, Greenville, NC 27858, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva F.","family":"Naidoo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Geisinger Wyoming Valley Medical Center, Wilkes-Barre, PA 18705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Humayun","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Geisinger Wyoming Valley Medical Center, Wilkes-Barre, PA 18705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4084-8404","authenticated-orcid":false,"given":"Hayrettin","family":"Okut","sequence":"additional","affiliation":[{"name":"Department of Population and Public Health, University of Kansas, Wichita, KS 67214, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Aziz","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Bon Secours Mercy Health, Toledo, OH 43608, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: A clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin. Res. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.21037\/atm-20-4354","article-title":"Non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: Mechanisms, treatment and prevention","volume":"9","author":"Tacke","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","article-title":"Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World","volume":"20","author":"Sayiner","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Chyau, C.C., Wang, H.F., Zhang, W.J., Chen, C.C., Huang, S.H., Chang, C.C., and Peng, R.Y. (2020). Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL\/6 Mice Model via AMPK\/Sirt1\/SREBP-1c\/PPAR\u03b3 Pathway. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21010360"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.apsb.2019.02.006","article-title":"Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway","volume":"9","author":"Liu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cld.1017","article-title":"Nonalcoholic fatty liver disease and cardiovascular disease","volume":"17","author":"Przybyszewski","year":"2021","journal-title":"Clin. Liver Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s10620-011-1819-3","article-title":"The relationship between arterial stiffness and nonalcoholic fatty liver disease","volume":"57","author":"Lee","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_11","first-page":"7673","article-title":"Association between nonalcoholic fatty liver disease and carotid atherosclerosis: A meta-analysis","volume":"8","author":"Cai","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s10620-019-05986-9","article-title":"Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany","volume":"65","author":"Labenz","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Friedrich-Rust, M., Schoelzel, F., Maier, S., Seeger, F., Rey, J., Fichtlscherer, S., Herrmann, E., Zeuzem, S., and Bojunga, J. (2017). Severity of coronary artery disease is associated with non-alcoholic fatty liver disease: A single-blinded prospective mono-center study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186720"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/eci.12065","article-title":"Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes","volume":"43","author":"Boddi","year":"2013","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.amjcard.2017.07.107","article-title":"Effect of Nonalcoholic Fatty Liver Disease on In-Hospital and Long-Term Outcomes in Patients with ST\u2013Segment Elevation Myocardial Infarction","volume":"120","author":"Keskin","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/MEG.0000000000001183","article-title":"Association of fatty liver index with the risk of incident cardiovascular disease and acute myocardial infarction","volume":"30","author":"Olubamwo","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_19","unstructured":"HCUP National Inpatient Sample (NIS) (2024, October 02). Healthcare Cost and Utilization Project (HCUP); Agency for Healthcare Research and Quality: Rockville, MD, USA, 2016\u20132019, Available online: https:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.amjcard.2017.07.081","article-title":"Comparison of Readmission Rates After Acute Myocardial Infarction in 3 Patient Age Groups (18 to 44, 45 to 64, and \u226565 Years) in the United States","volume":"120","author":"Khera","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4254\/wjh.v12.i7.378","article-title":"Non-alcoholic steatohepatitis and the risk of myocardial infarction: A population-based national study","volume":"12","author":"Ghoneim","year":"2020","journal-title":"World J. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"E98","DOI":"10.25270\/jic\/21.00096","article-title":"A Comparison of In-Hospital Outcomes Between the Use of Impella and IABP in Acute Myocardial Infarction Cardiogenic Shock Undergoing Percutaneous Coronary Intervention","volume":"34","author":"Jin","year":"2022","journal-title":"J. Invasive Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/amiajnl-2011-000782","article-title":"Patient characteristics associated with venous thromboembolic events: A cohort study using pooled electronic health record data","volume":"19","author":"Kaelber","year":"2012","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0035-1562943","article-title":"Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease","volume":"35","author":"Satapathy","year":"2015","journal-title":"Semin. Liver Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000282088","article-title":"The role of non-alcoholic fatty liver disease in cardiovascular disease","volume":"28","author":"Perseghin","year":"2010","journal-title":"Dig. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.atherosclerosis.2008.07.024","article-title":"Nonalcoholic fatty liver disease severity is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects","volume":"203","author":"Sung","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1007\/s10620-009-1075-y","article-title":"The inflamed liver and atherosclerosis: A link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk","volume":"55","author":"Alkhouri","year":"2010","journal-title":"Dig. Dis. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","article-title":"Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome","volume":"28","author":"Adiels","year":"2008","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: Pathophysiological, genetic, and therapeutic insights: A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Chapman","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1089\/met.2019.0115","article-title":"High-risk atherosclerosis and metabolic phenotype: The roles of ectopic adiposity, atherogenic dyslipidemia, and inflammation","volume":"18","author":"Lechner","year":"2020","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart: JACC state of the art review","volume":"73","author":"Stahl","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/j.dsx.2016.12.033","article-title":"Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis","volume":"11","author":"Hamdeh","year":"2017","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Osawa, K., Miyoshi, T., Yamauchi, K., Koyama, Y., Nakamura, K., Sato, S., Kanazawa, S., and Ito, H. (2015). Nonalcoholic hepatic steatosis is a strong predictor of high-risk coronaryartery plaques as determined by multidetector CT. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0131138"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.118.037137","article-title":"Twenty Year Trends and Sex Differences in Young Adults Hospitalized with Acute Myocardial Infarction","volume":"139","author":"Arora","year":"2019","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa0908610","article-title":"Population trends in the incidence and outcomes of acute myocardial infarction","volume":"362","author":"Yeh","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/CIRCULATIONAHA.109.862094","article-title":"Recent declines in hospitalizations for acute myocardial infarction for Medicare fee-for-service beneficiaries: Progress and continuing challenges","volume":"121","author":"Chen","year":"2010","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e001197","DOI":"10.1161\/JAHA.114.001197","article-title":"National trends in recurrent AMI hospitalizations 1 year after acute myocardial infarction in Medicare beneficiaries: 1999\u20132010","volume":"3","author":"Chaudhry","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ahj.2015.04.027","article-title":"Trends in mortality and recurrent coronary heart disease events after an acute myocardial infarction among Medicare beneficiaries, 2001\u20132009","volume":"170","author":"Brown","year":"2015","journal-title":"Am. Heart J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ahj.2003.10.023","article-title":"Recent and temporal trends (1975 to 1999) in the treatment, hospital, and long-term outcomes of Hispanic and non-Hispanic white patients hospitalized with acute myocardial infarction: A population-based perspective","volume":"147","author":"Yarzebski","year":"2004","journal-title":"Am. Heart J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1161\/CIRCULATIONAHA.110.973628","article-title":"Differences in admitting hospital characteristics for black and white Medicare beneficiaries with acute myocardial infarction","volume":"123","author":"Popescu","year":"2011","journal-title":"Circulation"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.amjcard.2018.02.036","article-title":"Racial differences in quality of care and outcomes after acute coronary syndrome","volume":"121","author":"Yong","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2306192","DOI":"10.1080\/07853890.2024.2306192","article-title":"The association of metabolic dysfunction-associated steatotic liver disease (MASLD) with the risk of myocardial infarction: A systematic review and meta-analysis","volume":"56","author":"Lv","year":"2024","journal-title":"Ann. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"101277","DOI":"10.1016\/j.jceh.2023.08.013","article-title":"The Independent Association of Non-alcoholic Fatty Liver Disease with Incident Cardiovascular Disease: A GRADE Evaluation of the Evidence Through a Systematic Review and Meta-analysis","volume":"14","author":"Prasad","year":"2024","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_45","first-page":"2157","article-title":"Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study","volume":"2001","author":"Goodpaster","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Li, F., Bai, T., Ren, Y., Xue, Q., Hu, J., and Cao, J. (2023). A systematic review and meta-analysis of the association between sarcopenia and myocardial infarction. BMC Geriatr., 23.","DOI":"10.1186\/s12877-022-03712-1"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/22\/6946\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:34:37Z","timestamp":1760114077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/22\/6946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":46,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["jcm13226946"],"URL":"https:\/\/doi.org\/10.3390\/jcm13226946","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]}}}